R. Kumar et al., EXPRESSION OF INFLAMMATORY CYTOKINES BY MURINE MACROPHAGES ACTIVATED WITH A NEW SYNTHETIC LIPOPEPTIDE JT3002, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(5), 1997, pp. 333-340
The present study was undertaken to investigate the effect of JT3002,
a new synthetic analogue of a lipoprotein from the outer wall of a gra
m-negative bacterium on the production of cytokines by mouse peritonea
l macrophages. Multilamellar liposomes containing different concentrat
ions of JT3002 induced production of the inflammatory cytokines tumor
necrosis factor-alpha, interleukin-1 alpha, and interleukin-6 by macro
phages in dose-and time-dependent manners. The presence of interferon-
gamma enhanced production of tumor necrosis factor-alpha by macrophage
s exposed to lower concentrations of JT3002 and induced the release of
nitric oxide, a potent cytolytic molecule of activated macrophages. U
nlike lipopolysaccharide, JT3002 activated macrophages independently o
f serum, but like lipopolysaccharide, it required protein tyrosine kin
ase.